Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-22T17:42:39.318Z Has data issue: false hasContentIssue false
  • English
  • Français

Compaction of Pharmaceuticals

Published online by Cambridge University Press:  29 November 2013

Nicholas G. Lordi  and
Alberto M. Cuitino
Get access

Extract

It has been estimated that more than 80% of all medication doses are administered as tablets—that is, in unit dosage forms prepared by compacting powders in dies. For drugs with acceptable oral-absorption profiles, the compacted tablet is the first choice as a delivery system in drug development. Modern tablets range in size from 25 milligrams (veterinary implants) to several grams (veterinary “boluses”). The most common tablet shape is the double convex-faced disk. Shapes range from capsule to triangular forms, in many instances with bisects embossed or debossed with identification codes and company logos. Tablets may be either film- or sugar-coated, may be designed for immediate or extended release, or may be prepared as multilayer or laminated forms. In addition to oral administration, tablets may be predissolved or designed to be disintegrated in the mouth, or may be administered by injection or as suppositories. Production rates for over-the-counter products such as acetaminophen tablets can exceed three 1,000-kg batches per week, requiring high-speed multiple-station tablet presses for production. In contrast, implants—which have low-volume market requirements—must be made under aseptic conditions on special singlestation presses.

Type
Compaction Science and Technology
Information
MRS Bulletin , Volume 22 , Issue 12 , December 1997 , pp. 34 - 37
Copyright
Copyright © Materials Research Society 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Lieberman, H.A., Lachman, L., and Schwartz, J.B., eds., Pharmaceutical Dosage Forms Tablets, 2nd ed., vols. 1, 2, and 3 (Marcel Dekker, Inc., New York, 1990).Google Scholar
2.Alderborn, G. and Nyström, C., eds., Pharmaceutical Powder Compaction Technology (Marcel Dekker, Inc., New York, 1996).Google Scholar
3.Watt, P.R., Tablet Machine Instrumentation in Pharmaceutics (John Wiley & Sons, New York, 1988).Google Scholar
4.The United States Pharmacopoeia 23/The National Formulary 18 (U.S. Pharmacopoeia Convention, Rockville, MD, 1995).Google Scholar
5.Skelley, J.P., Amidon, G.L., Barr, W.H., Benet, L.Z., Carter, J.E., Robinson, J.R., Shah, V.P., and Yacob, A., J. Pharm. Sci. 13 (1990) p. 849.CrossRefGoogle Scholar
6.Seugling, E.W., Pharm. Technol. 4 (7) (1980) p. 27.Google Scholar
7.Pietsch, W., Chem. Eng. Prog. 13 (4) (1997) p. 24.Google Scholar
8.Martin, S.A. and Bogda, M.J., Pharm. Technol. 13 (7) (1988) p. 26; Manufacturer's Literature, Elizabeth-Hata.Google Scholar
9.Tableting Specification Manual, 4th ed. (APHA, Washington, DC, 1996).Google Scholar
10.Celik, M. and Lordi, N.G., Pharm. Technol. 13 (3) (1991) p. 112.Google Scholar
11.Tomosawa, H. and Lordi, N.G. (unpublished).Google Scholar
12.Sharpe, S.A., PhD dissertation, Rutgers University, 1996.Google Scholar
13.Paronen, P. and Ilkka, J., in Pharmaceutical Powder Compaction Technology, edited by Alderborn, G. and Nyström, C. (Marcel Dekker, Inc., New York, 1996) p. 55.Google Scholar
14.Lordi, N.G., Cocolas, H., and Yamasaki, H., Powder Technol. 13 (1997) p. 173.CrossRefGoogle Scholar
15.Leuenberger, H., Leu, R., and Bonny, J., in Pharmaceutical Powder Compaction Technology, edited by Alderborn, G. and Nyström, C. (Marcel Dekker, Inc., New York, 1996) p. 133.Google Scholar